GB202104128D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB202104128D0
GB202104128D0 GBGB2104128.0A GB202104128A GB202104128D0 GB 202104128 D0 GB202104128 D0 GB 202104128D0 GB 202104128 A GB202104128 A GB 202104128A GB 202104128 D0 GB202104128 D0 GB 202104128D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2104128.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nxera Pharma UK Ltd
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Priority to GBGB2104128.0A priority Critical patent/GB202104128D0/en
Publication of GB202104128D0 publication Critical patent/GB202104128D0/en
Ceased legal-status Critical Current

Links

GBGB2104128.0A 2021-03-24 2021-03-24 Antibodies Ceased GB202104128D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2104128.0A GB202104128D0 (en) 2021-03-24 2021-03-24 Antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2104128.0A GB202104128D0 (en) 2021-03-24 2021-03-24 Antibodies

Publications (1)

Publication Number Publication Date
GB202104128D0 true GB202104128D0 (en) 2021-05-05

Family

ID=75689987

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2104128.0A Ceased GB202104128D0 (en) 2021-03-24 2021-03-24 Antibodies

Country Status (1)

Country Link
GB (1) GB202104128D0 (en)

Similar Documents

Publication Publication Date Title
RS64645B1 (en) Antibodies against sars-cov-2
IL289112A (en) Anti-tigit antibodies
IL291068A (en) Anti-cd73 antibodies
IL284584A (en) Anti-tigit antibodies
IL308741A (en) Anti-sirp-alpha antibodies
GB201905150D0 (en) Ant-ige antibodies
GB201917480D0 (en) Antibodies
GB201900732D0 (en) Antibodies
IL300142A (en) ANTI-IL13Ralpha2 ANTIBODIES
GB202105110D0 (en) Anti-CD73 antibodies
IL289160A (en) Anti-angpt2 antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
GB202015115D0 (en) ZIP12 Antibody
IL311043A (en) Anti-il-11rα antibodies
IL310245A (en) Anti-hla-g antibodies
GB202208773D0 (en) Anti-SARS2-S antibodies
IL308782A (en) Antibodies
IL308100A (en) Antibodies
IL307175A (en) Il-38-specific antibodies
GB202116709D0 (en) Antibodies
GB202115824D0 (en) Antibodies
GB202112297D0 (en) Antibodies
IL299767A (en) Anti-αlpha-4-βeta-7 antibodies
GB202107517D0 (en) Antibodies
GB202104128D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)